Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 55

Sort by

Sort Order Select

Journal Articles

A Phase II Trial to Compare Allogeneic Transplant Vs. Standard of Care for Severe Sickle Cell Disease: Blood and Marrow Transplant Clinical Trials Network (BMT CTN) Protocol 1503

Mary Eapen, MBBS, MS, Donna S Neuberg, ScD, Adam M. Mendizabal, MS, Kristen E. Stevenson, MS, Joseph H. Antin, MD, Nancy DiFronzo, PhD, Fuad A El Rassi, MD, Premal Lulla, MBBS, Edmund K. Waller, PhDMD, Jamie Garrison, Shannon Smith, MSN, Keith Sullivan, MD, Mark C. Walters, MD, Lakshmanan Krishnamurti, MD

Blood (2019) 134 (Supplement_1): 4592.

https://doi.org/10.1182/blood-2019-126793

Published: 2019

Journal Articles

Rationale and Design of a Phase 3 Study to Evaluate the Efficacy and Safety of ION-682884 in Patients with Transthyretin-Mediated Amyloid Cardiomyopathy (ATTR-CM)

Rodney H Falk, MD, Morie A Gertz, MD, Merrill D Benson, MD, Gustavo Buchele, MD PhD, Michela Brambatti, MD MS, Sotirios Tsimikas, MD, Nicholas J Viney, Bsc, Li-Jung Tai, MD PhD, Cecilia Monteiro, MD PhD, Qingqing Yang, MS, Louis St L O'Dea, MB B.Ch. BAO, FRCP, Ewa Karwatowska-Prokopczuk, MD PhD, Eugene Schneider, MD, Richard S Geary, PhD, Brett P Monia, PhD

Blood (2019) 134 (Supplement_1): 5764.

https://doi.org/10.1182/blood-2019-129269

Published: 2019

Journal Articles

The Role of SOD2 in Maintaining Endothelial Cell Function in SCD

Atinuke Dosunmu-Ogunbi, Yingze Zhang, PhD, Seyed Mehdi Nouraie, PhD MD, Adam Straub, PhD

Blood (2019) 134 (Supplement_1): 3563.

https://doi.org/10.1182/blood-2019-131238

Published: 2019

Journal Articles

Results of the Phase 3 VITAL Study of NEOD001 (Birtamimab) Plus Standard of Care in Patients with Light Chain (AL) Amyloidosis Suggest Survival Benefit for Mayo Stage IV Patients

Morie A Gertz, MD, Adam D. Cohen, MD, Raymond L Comenzo, MD, Charles Du Mond, Eftathios Kastritis, Heather J Landau, MD, Edward N. Libby, III, MD, Michaela Liedtke, MD, Giampaolo Merlini, MD, Vaishali Sanchorawala, MD, Stefan O. Schönland, MD, Ashutosh D Wechalekar, MBBS, MD FRCP, FRCPath, DM, Jeffrey A. Zonder, Gene Kinney, PhD

Blood (2019) 134 (Supplement_1): 3166.

https://doi.org/10.1182/blood-2019-124482

Published: 2019

Journal Articles

Improvement of the Six-Minute Walk Test in Children with Sickle Cell Disease over Time

Geoffrey Bourg, MD, Laurence Dedeken, MD, Phu-Quoc Le, MD PhD, Laurence Rozen, Safiatou Diallo, MD, Sabine Amah, MD, Christine Devalck, MD, Catherine Heijmans, MD, Laurence Hanssens, MD, Rossana Pavone, MD, Malou Ngalula Mujinga, Alina Ferster, MD

Blood (2018) 132 (Supplement 1): 1085.

https://doi.org/10.1182/blood-2018-99-118373

Published: 2018

Journal Articles

Exercise and Chronic Lymphocytic Leukemia (CLL) - Relationships Among Physical Activity, Fitness, & Inflammation, and Their Impacts on CLL Patients

Andrea Sitlinger, MD, Dana P Thompson, PhD, Michael A Deal, BS, Erwin Garcia, PhD, Tiffany Stewart, BS, Eross Guadalupe, BS, J. Brice Weinberg, MD, David A Bartlett, PhD, Danielle M. Brander, MD

Blood (2018) 132 (Supplement 1): 5540.

https://doi.org/10.1182/blood-2018-99-117736

Published: 2018

Journal Articles

The Impact of a Physical Activity Intervention Can be Accurately Assessed By Smart Watches in Patients Completing Autologous Stem Cell Transplantation for Lymphoma or Multiple Myeloma: Results of a Feasibility Study

Blood (2018) 132 (Supplement 1): 5911.

https://doi.org/10.1182/blood-2018-99-119757

Published: 2018

Journal Articles

Diastolic Dysfunction Is Associated with Impaired Cardiopulmonary Exercise Performance in Sickle Cell Disease

Tarek Alsaied, MD MSc, Omar Niss, MD, Adam Powell, MD, Robert Fleck, MD, Punam Malik, MD, Clifford Chin, MD, Charles T. Quinn, MD MS, Michael D Taylor

Blood (2017) 130 (Supplement 1): 3547.

https://doi.org/10.1182/blood.V130.Suppl_1.3547.3547

Published: 2017

Journal Articles

Prospective Controlled Trial on Endurance Exercise Training in Adult Sickle Cell Disease Patients

Barnabas Gellen, Laurent Messonnier, Angele Merlet, Etienne Audureau, Thomas Rupp, Sandrine Peyrot, Cyril Martin, PhD, Jean-Antoine Ribeil, MD PhD, jean Benoit Arlet, Frédéric Galactéros, MDPhD, Leonard Feasson, Pablo Bartolucci, MD PhD

Blood (2017) 130 (Supplement 1): 991.

https://doi.org/10.1182/blood.V130.Suppl_1.991.991

Published: 2017

Journal Articles

Effect of RBC Transfusion on Six Minute Walk Test Performance and Quality of Life in Outpatients

Elizabeth St Lezin, MD, Matthew Karafin, MD, Roberta Bruhn, PhD MS, Dhuly Chowdhury, MS, MBA, Lirong Qu, MD PhD, Walter Bialkowski, MS, Scott Merenda, BSN, Lisa Anderson, Pamela D'Andrea, RN, Anne-Lyne McCalla, MPH, Edward L Snyder, MD, Edward L Murphy, MD MPH, Donald Brambilla, PhD, Philip L Norris, MD, Bryan R Spencer, MPH, Steven Kleinman, MD, Jeffrey L Carson, MD, For the NHLBI Recipient Epidemiology and Donor Evaluation Study-III

Blood (2017) 130 (Supplement 1): 2400.

https://doi.org/10.1182/blood.V130.Suppl_1.2400.2400

Published: 2017

Journal Articles

Ventilation-Perfusion Scan Is Superior to CT Pulmonary Angiography in Detection of Chronic Thromboembolic Pulmonary Hypertension in SCD Adults

Alem Mehari, MD MS, Norris E. Igbineweka, MBBS, BSc (Hons), MRCP, Darlene Allen, MT(ASCP), James Nichols, RN, Swee Lay Thein, DSc,FRCP,FRCPath,MBBS,MRCPath,MRCP, Nargues Weir, MD

Blood (2017) 130 (Supplement 1): 2248.

https://doi.org/10.1182/blood.V130.Suppl_1.2248.2248

Published: 2017

Journal Articles

Reduced Physical Activity Level and Cardiorespiratory Fitness in Children after Acute Venous Thromboembolism

Zhuo Yang, BA, Kendra Malone, MPH, Ayesha Zia, MD

Blood (2017) 130 (Supplement 1): 4900.

https://doi.org/10.1182/blood.V130.Suppl_1.4900.4900

Published: 2017

Journal Articles

SCD-101: A New Anti-Sickling Drug Reduces Pain and Fatigue and Improves Red Blood Cell Shape in Peripheral Blood of Patients with Sickle Cell Disease

Robert Swift, PhD, Osheiza Abdulmalik, DVM, MS, Qiukan Chen, Toshio Asakura, MD PhD, Kelsey Gustafson, MS, James E Simon, PhD, Virdah Zaman, MS, Kevin Alexis Quiusky, MD, Kathryn L. Hassell, MD, Iuliana Shapira, MD, Gurinder Sidhu, MD, Tracian James-Goulbourne, MD, Kisha Carrington, MD, John Muthu, MD, Peter N Gillette, MD

Blood (2016) 128 (22): 121.

https://doi.org/10.1182/blood.V128.22.121.121

Published: 2016

Journal Articles

Implementation of a Physician-Prescribed Exercise Program As Standard of Care in Allogeneic Stem Cell Transplant (SCT) Patients (pts) in British Columbia: A Pilot Study

Alina S. Gerrie, MD MPH, FRCPC, Pamela Plantinga, Kei Nishikawa, MScPT, Stanley Hung, MSc, Jennifer Kadgien, MScPT, Ben Chernoff, BSc, Valerie Burke, RN, David Kendler, MD FRCPC, Don C McKenzie, MD FRCPC, Kristin L Campbell, MScPT, PhD, Raewyn Broady, MBChB, FRACP

Blood (2016) 128 (22): 3603.

https://doi.org/10.1182/blood.V128.22.3603.3603

Published: 2016

Journal Articles

Predictors of Quality of Life, Dyspnea, and Walking Distance during 1 Year Follow-up after a First Episode of Pulmonary Embolism: Extended Results of the E.L.O.P.E. Study

Susan R. Kahn, MD, Arash Akaberi, MSc, Andrew M Hirsch, MD, John T Granton, MD

Blood (2016) 128 (22): 3530.

https://doi.org/10.1182/blood.V128.22.3530.3530

Published: 2016

Journal Articles

A Multi-Center, Phase-2 Trial of Losartan for the Nephropathy of Sickle Cell Anemia

Charles T. Quinn, MD MS, Santosh L. Saraf, MD, Victor R. Gordeuk, MD, Courtney D. Fitzhugh, MD, Susan E Creary, MD MSc, Prasad Bodas, MD, Alex George, MD, PhD, Ashok Raj, MD, Alecia C. Nero, MD, Catherine Terrell, BS, Lisa McCord, BS, Omar Niss, MD, Rubina Dosani, MS, Michael D. Taylor, MD, Prasad Devarajan, MD, Punam Malik, MD

Blood (2016) 128 (22): 265.

https://doi.org/10.1182/blood.V128.22.265.265

Published: 2016

Journal Articles

Patient-Reported Outcomes and Patient-Performed Testing in Measuring Functional Impairment after Stem Cell Transplant in Patients with Multiple Myeloma

Nina Shah, MD, Sergio A. Giralt, MD, Qiuling Shi, PhD, Loretta A. Williams, PhD APRN, Qaiser Bashir, MD, Muzaffar Qazilbash, MD, Richard E. Champlin, MD, Charles S. Cleeland, PhD, Xin Shelley Wang, MD MPH

Blood (2016) 128 (22): 538.

https://doi.org/10.1182/blood.V128.22.538.538

Published: 2016

Journal Articles

The VITAL Amyloidosis Study: A Randomized, Double-Blind, Placebo-Controlled, Global, Phase 3 Study of NEOD001 in Patients with AL Amyloidosis and Cardiac Dysfunction

Michaela Liedtke, MD, Giampaolo Merlini, MD, Heather Landau, MD, Raymond L. Comenzo, MD, Vaishali Sanchorawala, MD, Brendan M. Weiss, MD, Jeffrey A. Zonder, MD, Jackie Walling, MBChB, PhD, Gene G. Kinney, PhD, Martin Koller, MD MPH, Morie A. Gertz, MD MACP

Blood (2016) 128 (22): 5690.

https://doi.org/10.1182/blood.V128.22.5690.5690

Published: 2016

Journal Articles

Challenges of Using NT-Probnp for Response Assessment in Systemic AL Amyloidosis - Analysis of a Prospective Study

Ashutosh Wechalekar, MD FRCPath, Darren Foard, Carol Whelan, MD FRCP, Mariana Fontana, Thirusha Lane, RN MSc, Candida Quarta, Shameem Mahmood, FRCPath, Helen Lachmann, MD FRCP, Julian D Gillmore, MD PhD FRCP, Philip N Hawkins, MD PhD FMedSci

Blood (2016) 128 (22): 4511.

https://doi.org/10.1182/blood.V128.22.4511.4511

Published: 2016

Journal Articles

Body Composition Predicts Survival in Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) Recipients

Asmita Mishra, MD, Binglin Yue, Martine Extermann, MD PhD, Claudio Anasetti, MD, Heather Jim, Jongphil Kim, Joseph A Pidala, MD, PhD, Vickie E Baracos

Blood (2015) 126 (23): 2113.

https://doi.org/10.1182/blood.V126.23.2113.2113

Published: 2015

NARROW

A Phase II Trial to Compare Allogeneic Transplant Vs. Standard of Care for Severe Sickle Cell Disease: Blood and Marrow Transplant Clinical Trials Network (BMT CTN) Protocol 1503

Rationale and Design of a Phase 3 Study to Evaluate the Efficacy and Safety of ION-682884 in Patients with Transthyretin-Mediated Amyloid Cardiomyopathy (ATTR-CM)

The Role of SOD2 in Maintaining Endothelial Cell Function in SCD

Results of the Phase 3 VITAL Study of NEOD001 (Birtamimab) Plus Standard of Care in Patients with Light Chain (AL) Amyloidosis Suggest Survival Benefit for Mayo Stage IV Patients

Improvement of the Six-Minute Walk Test in Children with Sickle Cell Disease over Time

Exercise and Chronic Lymphocytic Leukemia (CLL) - Relationships Among Physical Activity, Fitness, & Inflammation, and Their Impacts on CLL Patients

The Impact of a Physical Activity Intervention Can be Accurately Assessed By Smart Watches in Patients Completing Autologous Stem Cell Transplantation for Lymphoma or Multiple Myeloma: Results of a Feasibility Study

Diastolic Dysfunction Is Associated with Impaired Cardiopulmonary Exercise Performance in Sickle Cell Disease

Prospective Controlled Trial on Endurance Exercise Training in Adult Sickle Cell Disease Patients

Effect of RBC Transfusion on Six Minute Walk Test Performance and Quality of Life in Outpatients

Ventilation-Perfusion Scan Is Superior to CT Pulmonary Angiography in Detection of Chronic Thromboembolic Pulmonary Hypertension in SCD Adults

Reduced Physical Activity Level and Cardiorespiratory Fitness in Children after Acute Venous Thromboembolism

SCD-101: A New Anti-Sickling Drug Reduces Pain and Fatigue and Improves Red Blood Cell Shape in Peripheral Blood of Patients with Sickle Cell Disease

Implementation of a Physician-Prescribed Exercise Program As Standard of Care in Allogeneic Stem Cell Transplant (SCT) Patients (pts) in British Columbia: A Pilot Study

Predictors of Quality of Life, Dyspnea, and Walking Distance during 1 Year Follow-up after a First Episode of Pulmonary Embolism: Extended Results of the E.L.O.P.E. Study

A Multi-Center, Phase-2 Trial of Losartan for the Nephropathy of Sickle Cell Anemia

Patient-Reported Outcomes and Patient-Performed Testing in Measuring Functional Impairment after Stem Cell Transplant in Patients with Multiple Myeloma

The VITAL Amyloidosis Study: A Randomized, Double-Blind, Placebo-Controlled, Global, Phase 3 Study of NEOD001 in Patients with AL Amyloidosis and Cardiac Dysfunction

Challenges of Using NT-Probnp for Response Assessment in Systemic AL Amyloidosis - Analysis of a Prospective Study

Body Composition Predicts Survival in Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) Recipients

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only